1%3A19-cv-07165 - Janssen Pharmaceuticals Inc et al. v. Lupin Pharmaceuticals Inc et al.Report Error
Detail
Case Number
1:19-cv-07165Current Status
closedCause of Action
Infringement
Related Case(s)
1:17-cv-05005
1:17-cv-05135
1:17-cv-07342
1:19-cv-07165
Court
New Jersey District CourtPlaintiff(s)
Janssen Pharmaceuticals Inc
Janssen Research & Development LLC
Janssen Pharmaceutica NV
Cilag GMBH International
Mitsubishi Tanabe Pharma Corp
Defendant(s)
Lupin Pharmaceuticals Inc
Lupin Ltd
Judge
Renee Marie BumbFiling Date
2019-02-27Termination Date
2019-05-02Dockets
Text |
---|
CIVIL DOCKET |
UPDATED CIVIL DOCKET |
CLERK`S QUALITY CONTROL MESSAGE - The Corporate Disclosure Statement filed by Amy Luria on 4/3/2019 was submitted incorrectly as an attachment to the Answer. PLEASE RESUBMIT THE Corporate Disclosure Statement USING Corporate Disclosure Statement found under Civil - Other Filings - Other Documents. This submission will remain on the docket unless otherwise ordered by the court. (mmh) (Entered: 04/03/2019) |
Judge Peter G. Sheridan and Magistrate Judge Douglas E. Arpert added. (jmh) (Entered: 02/28/2019) |
TEXT ORDER REASSIGNING CASE. Case reassigned to Judge Michael A. Shipp for all further proceedings. Judge Peter G. Sheridan no longer assigned to case. So Ordered by Chief Judge Freda L. Wolfson on 10/8/2019. (jjc, ) (Entered: 10/08/2019) |
COMPLAINT against LUPIN LIMITED, LUPIN PHARMACEUTICALS, INC. ( Filing and Admin fee $ 400 receipt number 0312-9455863), filed by MITSUBISHI TANABE PHARMA CORPORATION, JANSSEN RESEARCH AND DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC., CILAG GMBH INTERNATIONAL. (Attachments: # 1 Civil Cover Sheet)(LIZZA, CHARLES) (Entered: 02/27/2019) |
ANSWER to Complaint , COUNTERCLAIM against CILAG GMBH INTERNATIONAL, JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH AND DEVELOPMENT, LLC, MITSUBISHI TANABE PHARMA CORPORATION by LUPIN LIMITED, LUPIN PHARMACEUTICALS, INC.. (Attachments: # 1 Statement Rule 7.1 Corporate Disclosure Statement)(LURIA, AMY) (Entered: 04/03/2019) |
ANSWER to Complaint , COUNTERCLAIM against CILAG GMBH INTERNATIONAL, JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH AND DEVELOPMENT, LLC, MITSUBISHI TANABE PHARMA CORPORATION by LUPIN LIMITED, LUPIN PHARMACEUTICALS, INC.. (Attachments: # 1 Statement Rule 7.1 Corporate Disclosure Statement)(LURIA, AMY) (Entered: 04/03/2019) |
ANSWER to Counterclaim by CILAG GMBH INTERNATIONAL, JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH AND DEVELOPMENT, LLC, MITSUBISHI TANABE PHARMA CORPORATION. (Attachments: # 1 Certificate of Service)(LIZZA, CHARLES) (Entered: 04/24/2019) |
CONSENT JUDGMENT AND ORDER that all affirmative defenses, claims and counterclaims, which have been or could have been raised by Plaintiffs against Hetero and its affiliates, or by Hetero and its affiliates against Plaintiffs, in this action solely with respect to the Hetero Product and the MTPC Patents are hereby dismissed with prejudice. Signed by Judge Peter G. Sheridan on 07/31/2019. (jmh) (Entered: 07/31/2019) |
Corporate Disclosure Statement by CILAG GMBH INTERNATIONAL, JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH AND DEVELOPMENT, LLC, MITSUBISHI TANABE PHARMA CORPORATION. (LIZZA, CHARLES) (Entered: 02/27/2019) |
AO120 Patent Form filed. (jmh) (Entered: 02/28/2019) |
SUMMONS ISSUED as to LUPIN LIMITED, LUPIN PHARMACEUTICALS, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jmh) (Entered: 02/28/2019) |
NOTICE of Appearance by WILLIAM C. BATON on behalf of CILAG GMBH INTERNATIONAL, JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH AND DEVELOPMENT, LLC, MITSUBISHI TANABE PHARMA CORPORATION (BATON, WILLIAM) (Entered: 02/28/2019) |
NOTICE of Appearance by SARAH ANN SULLIVAN on behalf of CILAG GMBH INTERNATIONAL, JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH AND DEVELOPMENT, LLC, MITSUBISHI TANABE PHARMA CORPORATION (SULLIVAN, SARAH) (Entered: 02/28/2019) |
NOTICE of Appearance by DAVID LEIGH MOSES on behalf of CILAG GMBH INTERNATIONAL, JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH AND DEVELOPMENT, LLC, MITSUBISHI TANABE PHARMA CORPORATION (MOSES, DAVID) (Entered: 02/28/2019) |
Corporate Disclosure Statement by LUPIN LIMITED, LUPIN PHARMACEUTICALS, INC.. (LURIA, AMY) (Entered: 04/03/2019) |
Letter from Plaintiffs to the Hon. Douglas E. Arpert, U.S.M.J.. (LIZZA, CHARLES) (Entered: 04/29/2019) |
ORDER that Civil Action No. 19-7165 (PGS)(DEA) and Civil Action No. Civil Action No. 17-5005 (PGS)(DEA) (collectively the "Consolidated Actions") are consolidated for all purposes, including discovery, case management, and trial, subject to further order of the Court; Civil Action No. 17-5005 shall be the Lead Case and all filings going forward that are common to all of the Consolidated Actions shall be filed in Civil Action No. 17-5005 only. Signed by Magistrate Judge Douglas E. Arpert on 4/29/2019. (jem) (Entered: 05/03/2019) |
ORDER that Civil Action No. 19-7165 (PGS)(DEA) and Civil Action No. Civil Action No. 17-5005 (PGS)(DEA) (collectively the "Consolidated Actions") are consolidated for all purposes, including discovery, case management, and trial, subject to further order of the Court; Civil Action No. 17-5005 shall be the Lead Case and all filings going forward that are common to all of the Consolidated Actions shall be filed in Civil Action No. 17-5005 only. Signed by Magistrate Judge Douglas E. Arpert on 4/29/2019. (jem) (Entered: 05/03/2019) |
ORDER REALLOCATING AND REASSIGNING CASE. Case Number 3:19-cv-7165. Case reallocated to Camden and reassigned to Judge Renee Marie Bumb and Magistrate Judge Joel Schneider for all further proceedings. Judge Michael A. Shipp, Magistrate Judge Douglas E. Arpert no longer assigned to case. Signed by Chief Judge Freda L. Wolfson on 10/11/2019. (jjc, ) (Entered: 10/11/2019) |
Timeline
filed_date
closed_date
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2020
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2021
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2022
Patents In Case